• Journal of Korean Neurosurgical Society
• /
• 제30권sup2호
• /
• pp.203-210
• /
• 2001

목 적 : Paraclinoidal aneurysm은 두개강내 내경동맥 근위부에서 후교통동맥 기시부까지 생기는 뇌동맥류를 말한다. 이들 동맥류의 수술의 기술적인 문제는 근위혈관의 지혈과 안전한 동맥류로의 접근 및 뇌동맥류 경부의 완전한 노출을 고려해야 한다. 저자들은 최소침윤법의 개념으로 수술의 효율성에 대해서 관심을 가지고 수술하였다. 대상 및 방법 : 저자들은 과거 4년간 171명의 뇌동맥류 수술환자를 경험하였으며 그중 10명의 paracliniodal aneurysm환자를 수술하였고 10명중 2명은 비파열된 동맥류를 가지고 있었다. 평균 연령은 47세 였으며 전부 여자 환자였다. 그중 3명의 환자는 proximal posterior carotid artery에서 기원하였으며 4명의 환자는 carotid-ophthalmic artery에서 기원했고 나머지 3명은 superior hypophyseal artery에서 기원하였다. 결 과 : 전례에서 결찰술을 시행했으며 수술결과는 매우 양호했으며, 이들 중 뇌수두증이 있었던 1례를 제외하고 신경학적인 결손과 사망한 환자는 없었다. 시력장애증상은 4명의 환자에서 호소했지만 그중 2명은 수술후 회복되었고 나머지 2명은 더 이상 악화되지는 않았다. 결 론 : 최근 저자들의 경험에 비추어 볼 때, 수술전 진단적 혈관조형술의 정교함이 크기와 무관하게 모든 paraclinoidal aneurysm의 분류에 도움이 된다고 생각하며, 이러한 분류가 각각의 동맥류에 따른 수술적 접근을 용이하게 함으로서 대부분의 환자에서 시각능력 향상뿐만 아니라 좋은 수술결과를 초래 할 수 있고 불필요한 수기를 배제함으로서 수술시간도 단축될 수 있을 것으로 사료된다.

• Journal of Korean Neurosurgical Society
• /
• 제40권2호
• /
• pp.128-130
• /
• 2006

Aneurysms arising from the ophthalmic artery itself are very rare compared with aneurysms originating from the bifurcation of the ophthalmic artery and carotid artery. There was only one reported case of a ruptured aneurysm of the ophthalmic artery itself. We discuss clinical significance of an aneurysm at this site, as well as the role of three dimentional image of multislice computed tomography angiogram[3D-image of MCTA] in determining the cause of subarachnoid hemorrhage[SAH].

• Journal of Korean Neurosurgical Society
• /
• 제45권4호
• /
• pp.236-239
• /
• 2009

Carotid occlusion is an inevitable therapeutic modality for the treatment of complex aneurysms such as giant, traumatic, and intracavernous aneurysms. Late complications of carotid occlusion include 'de novo' aneurysm formation at a distant site because of hemodynamic changes in the circle of Willis. We report a case of de novo aneurysm in a vessel that appeared to be normal on initial angiography. The patient developed an anterior communicating artery aneurysm and marked growth of a basilar bifurcation aneurysm 9 years after trapping of the left internal carotid artery for the treatment of a ruptured large saccular aneurysm involving ophthalmic and cavernous segments. We propose that patients who undergo therapeutic carotid occlusion should be periodically followed by magnetic resonance angiography or computed tomographic angiography to evaluate the possibility of de novo aneurysm formation; this advice is in line with previous reports.

• Journal of Korean Neurosurgical Society
• /
• 제30권sup2호
• /
• pp.337-339
• /
• 2001

The development of completely new intracranial aneurysms after previous successfully treated aneurysm is uncommon. A 50-year-old female presented with a case of multiple de novo aneurysm which were an aneurysm of right ophthalmic segment of internal carotid artery and an aneurysm of right A1 artery, 6 years after the clipping of an aneurysm of right posterior communicating artery. She had no history of hypertension, cigarette smoking and use of oral contraceptives, and had no evidence of genetic disorder. The laboratory findings were normal. All de novo aneurysms were clipped by basal anterior interhemispheric approach in one stage due to the direction of the aneurysm of the ophthalmic segment of the internal carotid artery.

• Journal of Korean Neurosurgical Society
• /
• 제63권2호
• /
• pp.137-152
• /
• 2020

In spite of the developing endovascular era, large (15-25 mm) and giant (>25 mm) wide-neck cerebral aneurysms remained technically challenging. Intracranial flow-diverting stents (FDS) were developed to address these challenges by targeting aneurysm hemodynamics to promote aneurysm occlusion. In 2011, the first FDS approved for use in the United States market. Shortly thereafter, the Pipeline of Uncoilable or Failed Aneurysms (PUFS) study was published demonstrating high efficacy and a similar complication profile to other intracranial stents. The initial FDA instructions for use (IFU) limited its use to patients 22 years old or older with wide-necked large or giant aneurysms of the internal carotid artery (ICA) from the petrous segment to superior hypophyseal artery/ophthalmic segment. Expanded IFU was tested in the Prospective Study on Embolization of Intracranial Aneurysms with PipelineTM Embolization Device (PREMIER) trial. With further post-approval clinical data, the United States FDA expanded the IFU to include patients with small or medium, wide-necked saccular or fusiform aneurysms from the petrous ICA to the ICA terminus. However, IFU is more restrictive in South Korea than in United States. Several systematic reviews and meta-analyses have sought to evaluate the overall efficacy of FDS for the treatment of cerebral aneurysms and consistently identify FDS as an effective technique for the treatment of aneurysms broadly with complication rates similar to other traditional techniques. A growing body of literature has demonstrated high efficacy of FDS for small aneurysms; distal artery aneurysms; non-saccular aneurysms posterior circulation aneurysms and complication rates similar to traditional techniques. In the short interval since the Pipeline Embolization Device was first introduced, FDS has been firmly entrenched as a powerful tool in the endovascular armamentarium. As new FDS are developed, established FDS are refined, and delivery systems are improved the uses for FDS will only expand further. Researchers continue to work to optimize the mechanical characteristics of the FDS themselves, aiming to optimize deploy ability and efficacy. With expanded use for small to medium aneurysms and posterior circulation aneurysms, FDS technology is firmly entrenched as a powerful tool to treat challenging aneurysms, both primarily and as an adjunct to coil embolization. With the aforementioned advances, the ease of FDS deployment will improve and complication rates will be further minimized. This will only further establish FDS deployment as a key strategy in the treatment of cerebral aneurysms.